Boill Healthcare Holdings Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Boill Healthcare Holdings.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Real Estate earnings growth	21.1%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

Recent updates

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 89% Share Price Slump

Jun 03

The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%

Apr 18

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump

Feb 05

Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Jul 31

Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S

Apr 18

There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital

Jul 22

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Jul 13

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Mar 21

Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?

Jan 27

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Dec 05

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Boill Healthcare Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SEHK:1246 - Analysts future estimates and past financials data (HKD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
3/31/2024	285	-119	N/A	N/A	N/A
9/30/2023	355	-203	-34	-34	N/A
6/30/2023	352	-213	17	17	N/A
3/31/2023	348	-224	68	68	N/A
9/30/2022	430	-30	-11	-12	N/A
6/30/2022	717	-21	-62	-63	N/A
3/31/2022	1,005	-12	-114	-114	N/A
12/31/2021	1,028	-299	-170	-168	N/A
9/30/2021	1,039	-81	-222	-222	N/A
6/30/2021	628	-112	-188	-188	N/A
3/31/2021	217	-142	-153	-153	N/A
12/31/2020	139	-172	-84	-85	N/A
9/30/2020	61	-201	-15	-16	N/A
6/30/2020	84	-195	26	28	N/A
3/31/2020	106	-189	68	73	N/A
12/31/2019	227	-185	215	230	N/A
9/30/2019	347	-181	362	388	N/A
6/30/2019	384	-190	382	407	N/A
3/31/2019	420	-200	402	426	N/A
12/31/2018	572	-232	N/A	N/A	N/A
9/30/2018	724	-237	382	388	N/A
6/30/2018	731	-225	339	342	N/A
3/31/2018	738	-214	295	297	N/A
12/31/2017	616	-298	N/A	N/A	N/A
9/30/2017	459	-412	N/A	11	N/A
6/30/2017	473	-491	N/A	-73	N/A
3/31/2017	487	-570	N/A	-157	N/A
12/31/2016	492	-450	N/A	-308	N/A
9/30/2016	485	-327	N/A	-371	N/A
6/30/2016	509	-260	N/A	-313	N/A
3/31/2016	532	-193	N/A	-254	N/A
12/31/2015	512	-113	N/A	-121	N/A
9/30/2015	492	-33	N/A	12	N/A
6/30/2015	525	29	N/A	35	N/A
3/31/2015	558	91	N/A	58	N/A
12/31/2014	562	84	N/A	73	N/A
9/30/2014	566	78	N/A	88	N/A
6/30/2014	527	76	N/A	70	N/A
3/31/2014	487	73	N/A	51	N/A
12/31/2013	441	69	N/A	57	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 1246's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 1246's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 1246's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 1246's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 1246's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 1246's Return on Equity is forecast to be high in 3 years time

Boill Healthcare Holdings Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Boill Healthcare Holdings Limited Provides Group Earning Guidance for the Financial Year Ended 31 March 2022

Recent updates

High number of new and inexperienced directors

Boill Healthcare Holdings Limited Announces Board Changes

Boill Healthcare Holdings Limited Announces Removal of Yuen Wai Keung as Company Secretary

Boill Healthcare Holdings Limited Announces Change of Directors and Change in Composition of Board Committees

Boill Healthcare Holdings Limited, Annual General Meeting, Sep 26, 2024

Full year 2024 earnings released: HK$0.087 loss per share (vs HK$0.17 loss in FY 2023)

Boill Healthcare Holdings Limited to Report Fiscal Year 2024 Results on Jun 28, 2024

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 89% Share Price Slump

New major risk - Market cap size

Boill Healthcare Holdings Limited Announces Company Secretary Changes

The Price Is Right For Boill Healthcare Holdings Limited (HKG:1246) Even After Diving 26%

Boill Healthcare Holdings Limited Announces Resignation of Qiu Bin as an Executive Director

Positive Sentiment Still Eludes Boill Healthcare Holdings Limited (HKG:1246) Following 33% Share Price Slump

Boill Healthcare Holdings Limited Announces Board Changes, Effective from January 27, 2024

Boill Healthcare Holdings Limited Announces Change of Company Secretary Andauthorised Representative Andappointment of Process Agent

First half 2024 earnings released

Boill Healthcare Holdings Limited to Report Q2, 2024 Results on Nov 24, 2023

Boill Healthcare Holdings Limited Announces Executive Changes

Boill Healthcare Holdings (HKG:1246) Has Debt But No Earnings; Should You Worry?

Full year 2023 earnings released: HK$0.17 loss per share (vs HK$0.009 loss in FY 2022)

New major risk - Market cap size

Boill Healthcare Holdings Limited, Annual General Meeting, Sep 27, 2023

Full year 2023 earnings released

New minor risk - Financial data availability

Boill Healthcare Holdings Limited to Report Fiscal Year 2023 Results on Jun 28, 2023

Lacklustre Performance Is Driving Boill Healthcare Holdings Limited's (HKG:1246) Low P/S

First half 2023 earnings released: HK$0.071 loss per share (vs HK$0.007 loss in 1H 2022)

Boill Healthcare Holdings Limited to Report First Half, 2023 Results on Nov 30, 2022

Less than half of directors are independent

Boill Healthcare Holdings Limited Approves Appointment of Directors

Full year 2022 earnings released: HK$0.38 loss per share (vs HK$0.13 loss in FY 2021)

Boill Healthcare Holdings Limited, Annual General Meeting, Sep 09, 2022

Boill Healthcare Holdings Limited Announces Board Retirements

There's Been No Shortage Of Growth Recently For Boill Healthcare Holdings' (HKG:1246) Returns On Capital

Full year 2022 earnings released: HK$0.38 loss per share (vs HK$0.13 loss in FY 2021)

Boill Healthcare Holdings Limited Provides Group Earning Guidance for the Financial Year Ended 31 March 2022

Boill Healthcare Holdings Limited to Report Fiscal Year 2022 Results on Jun 30, 2022

Insufficient new directors

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Full year 2021 earnings released: HK$0.13 loss per share (vs HK$0.21 loss in FY 2020)

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

Have Insiders Been Buying Boill Healthcare Holdings Limited (HKG:1246) Shares This Year?

New 90-day low: HK$0.22

First half 2021 earnings released: HK$0.078 loss per share

Is Boill Healthcare Holdings (HKG:1246) A Risky Investment?

First half 2021 earnings released: HK$0.078 loss per share

Boill Healthcare Holdings Limited to Report First Half, 2021 Results on Nov 27, 2020

New 90-day low: HK$0.26

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies